Unbiased identification of cell identity in dense mixed neural cultures.

in eLife by Sarah De Beuckeleer, Tim Van De Looverbosch, Johanna Van Den Daele, Peter Ponsaerts, Winnok H De Vos

TLDR

  • Summary

Abstract

Induced pluripotent stem cell (iPSC) technology is revolutionizing cell biology. However, the variability between individual iPSC lines and the lack of efficient technology to comprehensively characterize iPSC-derived cell types hinder its adoption in routine preclinical screening settings. To facilitate the validation of iPSC-derived cell culture composition, we have implemented an imaging assay based on cell painting and convolutional neural networks to recognize cell types in dense and mixed cultures with high fidelity. We have benchmarked our approach using pure and mixed cultures of neuroblastoma and astrocytoma cell lines and attained a classification accuracy above 96%. Through iterative data erosion, we found that inputs containing the nuclear region of interest and its close environment, allow achieving equally high classification accuracy as inputs containing the whole cell for semi-confluent cultures and preserved prediction accuracy even in very dense cultures. We then applied this regionally restricted cell profiling approach to evaluate the differentiation status of iPSC-derived neural cultures, by determining the ratio of postmitotic neurons and neural progenitors. We found that the cell-based prediction significantly outperformed an approach in which the population-level time in culture was used as a classification criterion (96%86%, respectively). In mixed iPSC-derived neuronal cultures, microglia could be unequivocally discriminated from neurons, regardless of their reactivity state, and a tiered strategy allowed for further distinguishing activated from non-activated cell states, albeit with lower accuracy. Thus, morphological single-cell profiling provides a means to quantify cell composition in complex mixed neural cultures and holds promise for use in the quality control of iPSC-derived cell culture models.

Overview

  • The study aimed to develop an imaging assay using cell painting and convolutional neural networks to recognize cell types in dense and mixed cultures with high fidelity.
  • The approach was benchmarked using pure and mixed cultures of neuroblastoma and astrocytoma cell lines and achieved a classification accuracy above 96%.
  • The study explored the application of regionally restricted cell profiling to evaluate the differentiation status of iPSC-derived neural cultures and identify cell composition in complex mixed neural cultures.

Comparative Analysis & Findings

  • The study compared the classification accuracy of inputs containing the nuclear region of interest and its close environment, and inputs containing the whole cell for semi-confluent cultures and preserved prediction accuracy even in very dense cultures.
  • The cell-based prediction significantly outperformed an approach in which the population-level time in culture was used as a classification criterion (96% vs 86%, respectively) in evaluating the differentiation status of iPSC-derived neural cultures.
  • In mixed iPSC-derived neuronal cultures, microglia could be unequivocally discriminated from neurons, regardless of their reactivity state, and a tiered strategy was developed to further distinguish activated from non-activated cell states, albeit with lower accuracy.

Implications and Future Directions

  • Morphological single-cell profiling provides a means to quantify cell composition in complex mixed neural cultures and holds promise for use in the quality control of iPSC-derived cell culture models.
  • Future studies could investigate the application of this approach to other cell types and lineages, as well as explore the use of this technology in routine preclinical screening settings.
  • The development of more robust and accurate classification methods, as well as the integration of this technology with other high-throughput screening techniques, could further enhance the utility of this approach in cell biology and regenerative medicine.